ALLMedicine™ Acute Leukemia Of Ambiguous Lineage Center

Dec 30th, 2020 - Red Plaques in a Pediatric Patient With Acute Leukemia of Ambiguous Lineage.|2020|Wallett A,Manudhane R,Lipsett J,|

Oct 29th, 2019 - Optimal chemotherapy for treating mixed-phenotype acute leukemia (MPAL) and the role of hematopoietic stem cell transplantation (HSCT) remain uncertain. Major limitations in interpreting available data are MPAL's rarity and the use of definitions ...

Aug 1st, 2019 - The 2017 Workshop of the Society for Hematopathology/European Association for Haematopathology examined the role of molecular genetics in the diagnosis and biology of acute leukemia. Acute leukemias were reviewed in two sessions: "Genetic Testing ...

Dec 5th, 2018 - Acute leukemia of ambiguous lineage (ALAL) is a rare group of blood cancers that cannot be clearly classified into either myeloid or lymphoid lineage through traditional immunophenotyping (2016 World Health Organization classification). In this st...

Nov 1st, 2018 - This study will be done in two parts: Part 1 - Dose Escalation: The goal of Part 1 of the study is to find the highest tolerable combination of venetoclax and chemotherapy that can be given to patients with leukemia. Part 2 - Dose Expansion: After...

Sep 30th, 2017 - The guideline provides a framework for the multiple steps, including laboratory testing, in the evaluation of acute leukemia samples. Some aspects of the guideline, especially molecular genetic testing in acute leukemia, are rapidly changing with.

Sep 30th, 2017 - Twenty-seven guideline statements were established, which ranged from recommendations on what clinical and laboratory information should be available as part of the diagnostic and prognostic evaluation of acute leukemia samples to what types of te.

Feb 28th, 2017 - Guide to intial diagnostic workup of acute leukemia.

Dec 30th, 2020 - Red Plaques in a Pediatric Patient With Acute Leukemia of Ambiguous Lineage.|2020|Wallett A,Manudhane R,Lipsett J,|

Oct 29th, 2019 - Optimal chemotherapy for treating mixed-phenotype acute leukemia (MPAL) and the role of hematopoietic stem cell transplantation (HSCT) remain uncertain. Major limitations in interpreting available data are MPAL's rarity and the use of definitions ...

Aug 1st, 2019 - The 2017 Workshop of the Society for Hematopathology/European Association for Haematopathology examined the role of molecular genetics in the diagnosis and biology of acute leukemia. Acute leukemias were reviewed in two sessions: "Genetic Testing ...

Dec 5th, 2018 - Acute leukemia of ambiguous lineage (ALAL) is a rare group of blood cancers that cannot be clearly classified into either myeloid or lymphoid lineage through traditional immunophenotyping (2016 World Health Organization classification). In this st...

Nov 1st, 2018 - This study will be done in two parts: Part 1 - Dose Escalation: The goal of Part 1 of the study is to find the highest tolerable combination of venetoclax and chemotherapy that can be given to patients with leukemia. Part 2 - Dose Expansion: After...

Aug 10th, 2018 - About Research in Context In this article, the authors of recent scholarship have been asked to discuss the implications of their research on federal health care providers and specifically the veteran and active-duty service member patient populat.

Aug 2nd, 2017 - Table of Contents The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA Systems Automation for Cancer Surveillance: A Lean Six Sigma Project for Tracking Care of Pat.

Abstract and Introduction Abstract Objectives: The 2017 Workshop of the Society for Hematopathology/European Association for Haematopathology examined the role of molecular genetics in the diagnosis and biology of acute leukemia. Methods: Acute le...

Abstract and Introduction Abstract Objectives: The 2017 Workshop of the Society for Hematopathology/European Association for Haematopathology examined the role of molecular genetics in the diagnosis and biology of acute leukemia. Methods: Acute le...